Security National Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $6K | Hold |
116
| – | – | ﹤0.01% | 360 |
|
|
2021
Q2 | $6K | Hold |
116
| – | – | ﹤0.01% | 371 |
|
|
2021
Q1 | $5K | Sell |
116
-2,120
| -95% | -$96.2K | ﹤0.01% | 371 |
|
|
2020
Q4 | $102K | Buy |
2,236
+320
| +17% | +$14.7K | 0.03% | 219 |
|
|
2020
Q3 | $90K | Sell |
1,916
-1,040
| -35% | -$52.1K | 0.03% | 218 |
|
|
2020
Q2 | $151K | Hold |
2,956
| – | – | 0.05% | 171 |
|
|
2020
Q1 | $140K | Sell |
2,956
-244
| -8% | -$13K | 0.05% | 161 |
|
|
2019
Q4 | $188K | Sell |
3,200
-144
| -4% | -$8.01K | 0.05% | 164 |
|
|
2019
Q3 | $178K | Hold |
3,344
| – | – | 0.06% | 163 |
|
|
2019
Q2 | $167K | Sell |
3,344
-80
| -2% | -$4.01K | 0.05% | 172 |
|
|
2019
Q1 | $179K | Buy |
3,424
+1,604
| +88% | +$80.2K | 0.06% | 162 |
|
|
2018
Q4 | $87K | Buy |
1,820
+80
| +5% | +$3.94K | 0.03% | 205 |
|
|
2018
Q3 | $87K | Sell |
1,740
-840
| -33% | -$42.7K | 0.03% | 225 |
|
|
2018
Q2 | $130K | Sell |
2,580
-40
| -2% | -$2.02K | 0.04% | 193 |
|
|
2018
Q1 | $128K | Hold |
2,620
| – | – | 0.04% | 196 |
|
|
2017
Q4 | $116K | Sell |
2,620
-5,916
| -69% | -$273K | 0.04% | 206 |
|
|
2017
Q3 | $433K | Hold |
8,536
| – | – | 0.14% | 116 |
|
|
2017
Q2 | $460K | Hold |
8,536
| – | – | 0.15% | 113 |
|
|
2017
Q1 | $449K | Hold |
8,536
| – | – | 0.15% | 116 |
|
|
2016
Q4 | $410K | Buy |
8,536
+560
| +7% | +$27.7K | 0.15% | 118 |
|
|
2016
Q3 | $430K | Buy |
7,976
+2,560
| +47% | +$140K | 0.16% | 114 |
|
|
2016
Q2 | $293K | Sell |
5,416
-218
| -4% | -$11.5K | 0.11% | 140 |
|
|
2016
Q1 | $286K | Buy |
5,634
+658
| +13% | +$32.8K | 0.11% | 142 |
|
|
2015
Q4 | $251K | Buy |
4,976
+116
| +2% | +$5.91K | 0.1% | 151 |
|
|
2015
Q3 | $234K | Buy |
4,860
+80
| +2% | +$4.16K | 0.09% | 160 |
|
|
2015
Q2 | $249K | Hold |
4,780
| – | – | 0.09% | 170 |
|
|
2015
Q1 | $276K | Hold |
4,780
| – | – | 0.1% | 163 |
|
|
2014
Q4 | $256K | Buy |
4,780
+68
| +1% | +$3.8K | 0.09% | 164 |
|
|
2014
Q3 | $271K | Sell |
4,712
-240
| -5% | -$14.7K | 0.11% | 147 |
|
|
2014
Q2 | $331K | Sell |
4,952
-80
| -2% | -$5.42K | 0.13% | 135 |
|
|
2014
Q1 | $336K | Sell |
5,032
-91
| -2% | -$6.15K | 0.14% | 131 |
|
|
2013
Q4 | $342K | Hold |
5,123
| – | – | 0.14% | 126 |
|
|
2013
Q3 | $321K | Buy |
5,123
+1,152
| +29% | +$74.2K | 0.14% | 121 |
|
|
2013
Q2 | $248K | Buy |
+3,971
| New | +$252K | 0.12% | 136 |
|
Other funds holding GSK
BCIM
Security National Trust's GSK Position: Q3 2021 in Review
Security National Trust held its GSK (GSK) position steady in Q3 2021 at 116 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #360.
Security National Trust first reported a position in GSK in Q2 2013 and has held it in 34 quarters since. The position peaked at $460K in Q2 2017. 793 funds tracked by Wall St. Rank hold GSK as of Q3 2021.
- Security National Trust held 116 shares of GSK worth $6K as of Q3 2021.
- Security National Trust left its GSK share count unchanged in Q3 2021.
- GSK made up ﹤0.01% of Security National Trust's portfolio in Q3 2021, its #360 holding.
- Security National Trust first reported a position in GSK in Q2 2013 and has held it in 34 quarters since.
- Security National Trust's GSK position peaked at $460K in Q2 2017.
- 793 funds tracked by Wall St. Rank held GSK as of Q3 2021.
Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.